FDA recall record

Fentanyl Citrate Inj., USP, CII, 250 mcg/5 mL (50 mcg/mL) (0.05 mg/mL) recall — FDA D-1139-2015

Failed Impurities/Degradation Specifications; 12 month stability testing (Expansion of RES #70548).

Class IIIclassification
D-1139-2015official record ID
Jun 24, 2015report date

Recall record at a glance

Official recordD-1139-2015
CategoryDrug Recalls
ClassificationClass III
FDA record statusTerminated
Recalling firmWest-Ward Pharmaceutical Corp.
Report dateJun 24, 2015
Recall initiation dateMay 13, 2015
Quantity14,649 Cartons
LocationEatontown, NJ, United States

Official product description

Fentanyl Citrate Inj., USP, CII, 250 mcg/5 mL (50 mcg/mL) (0.05 mg/mL), Rx Only, For IV or IM Use Preservative Free, 25 X 5 mL Single Dose Vials per Carton, Manufactured by: West-Ward, Eatontown, NJ 07724 USA, NDC 0641-6028-25.

Why the product was recalled

Failed Impurities/Degradation Specifications; 12 month stability testing (Expansion of RES #70548).

Distribution information

Nationwide

How to read the classification

FDA Class III generally covers situations in which use of or exposure to the product is not likely to cause adverse health consequences. The classification displayed here is taken from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.